Anthhropological and genetic studies on ocular inflammatory diseases in Mongoloids

蒙古人种眼部炎症疾病的人类学和遗传学研究

基本信息

  • 批准号:
    10041203
  • 负责人:
  • 金额:
    $ 6.85万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

It is well known that certain intractable inflammatory ocular diseases occur only in Mongoloid population. We have been studying the epidemiology, clinical feature, medical anthropology, and molecular genetics in mainly Vogt-Koyanagi-Harada disease and Behcet's disease.It was revealed that Vogt-Koyanagi-Harada disease was found in East Asian countries, Central Asian countries, North America and South America. In contrast, in Caucasians, this disease was rarely found. Vogt-Koyanagi-Harada disease was frequently seen in Australian Aborigini people, and possibly, in Papua New Guinean population. Since this disease is strongly associated with HLA-DRB1ィイD1*ィエD104 in East Asian patients, it is important to further study if the same HLA association is found in other populations.In Behcet's disease, no patients were found in East Asian countries. This disease was mainly found along the Silk Road, such as Korea, China, Iran, Turkey, and Morocco. In these countries, the number of new cases is still increasing and further epidemiological studies are needed to investigate the possible cause for this. In 1998's investigation we saw patients with Behcet's disease in Mongolia. This is the first report of the world. We have finished analyzing the molecular genetics of Greek patients with Behcet's disease. The frequency of HLA-BィイD1*ィエD15101 was 81.1 %, significantly higher than the healthy normal Greek controls. MICA-A6, one of the microsatellite alleles near the HLA region, was also significantly associated with this disease. It was interesting to find the same HLA association between Japanese and Greek patients with Behcet's disease.We have successfully gotten the blood samples from typical patients with Behcet's disease in Iran and Turkey. And it is expected that we could also get the samples from Morocco. Further HLA-DNA analyses will be performed in the near future.
众所周知,某些难治性炎症性眼病仅发生在蒙古人种中,我们一直在研究主要是Vogt-Koyanagi-Harada病和Behcet病的流行病学、临床特征、医学人类学和分子遗传学。小柳原田病见于东亚国家、中亚国家、北美和南美,而在白种人中则很少见。 Vogt-Koyanagi-Harada 病常见于澳大利亚原住民,也可能见于巴布亚新几内亚人群,因为这种疾病与东亚患者的 HLA-DRB1D1*D104 密切相关,因此进一步研究是否存在相同的 HLA 非常重要。在其他人群中也发现了这种关联。在白塞氏病中,没有发现患者,该病主要发现于丝绸之路沿线国家,如韩国、中国、伊朗、土耳其和摩洛哥这些国家的新病例数量仍在增加,需要进一步的流行病学研究来调查其可能的原因。1998年的调查中,我们在蒙古发现了白塞氏病患者。我们已经完成了希腊白塞氏病患者的分子遗传学分析,HLA-B*D1*D15101 的频率为 81.1。 %,显着高于健康正常希腊对照,MICA-A6(HLA 区域附近的微卫星等位基因之一)也与这种疾病显着相关。有趣的是,在日本和希腊白塞氏病患者之间发现了相同的 HLA 关联。我们已经成功地从伊朗和土耳其获取了典型白塞氏病患者的血液样本,预计近期也可以从摩洛哥获取样本进行进一步的HLA-DNA分析。未来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yabuki K.: "Uveitis Update (Dev Ophthalmol)"Karger. 216 (1999)
Yabuki K.:“葡萄膜炎更新(Dev Ophamol)”Karger。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Goto K.: "Ocular Inflammation (Basic and Clinical Concepts)"Martion Dunitz. 512 (1999)
Goto K.:“眼部炎症(基本和临床概念)”Martion Dunitz。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nanba K.: "Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice"Cliln Exp Immunol. 111. 442-449 (1998)
Nanba K.:“在 H-2Ak 携带小鼠中诱导实验性自身免疫性葡萄膜视网膜炎 (EAU) 的肽的鉴定”Ciln Exp Immunol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yawata N.: "High incidence of glucose intolerance in Vogt-Koyanagi-Harada disease"Br J Ophthalmol. 83. 39-42 (1999)
Yawata N.:“Vogt-Koyanagi-Harada 病中葡萄糖不耐受的发生率很高”Br J Ophamol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yabiki K.: "Triplet repeat polymorphism in the MICA gene in HLA-B27 positive and negative Caucasian patients with ankylosing spondylitis"Hum Immunol. 60. 83-86 (1999)
Yabiki K.:“HLA-B27 阳性和阴性白种人强直性脊柱炎患者的 MICA 基因中的三重重复多态性”Hum Nutrition。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OHNO Shigeaki其他文献

OHNO Shigeaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OHNO Shigeaki', 18)}}的其他基金

Comprhensive examination for serum autoantigens in endogenous uveitis patients
内源性葡萄膜炎患者血清自身抗原的综合检查
  • 批准号:
    23592602
  • 财政年份:
    2011
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of disease susceptibility genes associated with intractable intraocular inflammation with racial differences and development of new antioxidant therapy
具有种族差异的顽固性眼内炎症相关疾病易感基因的研究及新型抗氧化疗法的开发
  • 批准号:
    19406028
  • 财政年份:
    2007
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular genetics and molecular epidemiology of intractable intraocular inflammation frequently found in Mongoloids for prevention of blindness.
蒙古人种中常见的难治性眼内炎症的分子遗传学和分子流行病学,用于预防失明。
  • 批准号:
    16406032
  • 财政年份:
    2004
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New development in molecular genetic and molecular pharmacological studies on intractable intraocular inflammation.
难治性眼内炎症的分子遗传学和分子药理学研究新进展。
  • 批准号:
    16209051
  • 财政年份:
    2004
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecule genetic and molecule immunologic investigations on the mechanisms of viral ocular inflammation
病毒性眼部炎症机制的分子遗传学和分子免疫学研究
  • 批准号:
    14370550
  • 财政年份:
    2002
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ANTHROPOLOGICAL AND MOLECULAR GENETIC STUDIES ON THE EPIDEMIOLOGY OF INTRACTABLE OCULAR DISEASES
难治性眼病流行病学的人类学和分子遗传学研究
  • 批准号:
    12576022
  • 财政年份:
    2000
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on molecular genetic mechanism of intractable immune-mediated inflammatory diseases of the eye by genomic analyses
通过基因组分析研究难治性免疫介导的眼部炎症性疾病的分子遗传机制
  • 批准号:
    12307038
  • 财政年份:
    2000
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular mechanism of intractable ocular diseases
眼部难治性疾病的分子机制
  • 批准号:
    10671650
  • 财政年份:
    1998
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular genetic studies on Behcet's disease
白塞病的分子遗传学研究
  • 批准号:
    08457466
  • 财政年份:
    1996
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Anthropological and genetic studies on uveitis in Mongoloids
蒙古人种葡萄膜炎的人类学和遗传学研究
  • 批准号:
    07041166
  • 财政年份:
    1995
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似海外基金

Development of therapeutically active nanomaterials: lipoprotein structure/function-based therapeutic strategies to treat intractable ocular diseases
治疗活性纳米材料的开发:基于脂蛋白结构/功能的治疗策略治疗难治性眼部疾病
  • 批准号:
    21H03821
  • 财政年份:
    2021
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ANTHROPOLOGICAL AND MOLECULAR GENETIC STUDIES ON THE EPIDEMIOLOGY OF INTRACTABLE OCULAR DISEASES
难治性眼病流行病学的人类学和分子遗传学研究
  • 批准号:
    12576022
  • 财政年份:
    2000
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of intractable ocular diseases
眼部难治性疾病的分子机制
  • 批准号:
    10671650
  • 财政年份:
    1998
  • 资助金额:
    $ 6.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了